Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 AUD | -4.76% | -5.51% | -24.05% |
18/04 | Acusensus Files Infringement Proceedings Against One Task | MT |
26/02 | Acusensus Narrows Loss in Fiscal H1 Despite 25% Rise in Revenue; Shares Jump 4% | MT |
Valuation
Fiscal Period: June | 2024 | 2025 | 2026 |
---|---|---|---|
Capitalization 1 | 75.85 | - | - |
Enterprise Value (EV) 1 | 54.35 | 57.45 | 60.05 |
P/E ratio | - | 300 x | 100 x |
Yield | - | - | - |
Capitalization / Revenue | 1.5 x | 1.28 x | 1.12 x |
EV / Revenue | 1.08 x | 0.97 x | 0.89 x |
EV / EBITDA | 13.3 x | 12.5 x | 11.8 x |
EV / FCF | -16.5 x | -18.5 x | -23.1 x |
FCF Yield | -6.07% | -5.4% | -4.33% |
Price to Book | - | - | - |
Nbr of stocks (in thousands) | 1,26,411 | - | - |
Reference price 2 | 0.6000 | 0.6000 | 0.6000 |
Announcement Date | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Net sales 1 | 28.73 | 50.4 | 59.1 | 67.5 |
EBITDA 1 | - | 4.1 | 4.6 | 5.1 |
EBIT 1 | - | -0.3 | 0.3 | 0.8 |
Operating Margin | - | -0.6% | 0.51% | 1.19% |
Earnings before Tax (EBT) | - | - | 0.3 | 0.8 |
Net income 1 | 1.426 | 0.1 | 0.3 | 0.8 |
Net margin | 4.96% | 0.2% | 0.51% | 1.19% |
EPS | - | - | 0.002000 | 0.006000 |
Free Cash Flow 1 | - | -3.3 | -3.1 | -2.6 |
FCF margin | - | -6.55% | -5.25% | -3.85% |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 10/01/23 | - | - | - |
Balance Sheet Analysis
Fiscal Period: June | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Net Debt 1 | - | - | - | - |
Net Cash position 1 | - | 21.5 | 18.4 | 15.8 |
Leverage (Debt/EBITDA) | - | - | - | - |
Free Cash Flow 1 | - | -3.3 | -3.1 | -2.6 |
ROE (net income / shareholders' equity) | - | -0.8% | 0.7% | 2.1% |
ROA (Net income/ Total Assets) | - | -0.6% | 0.5% | 1.4% |
Assets 1 | - | -16.67 | 60 | 57.14 |
Book Value Per Share | - | - | - | - |
Cash Flow per Share | - | - | - | - |
Capex 1 | - | 5 | 5 | 5 |
Capex / Sales | - | 9.92% | 8.46% | 7.41% |
Announcement Date | 10/01/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.05% | 53.22M | |
-6.16% | 188B | |
+24.49% | 92.88B | |
+57.34% | 65.47B | |
+17.93% | 61.11B | |
+26.83% | 31.35B | |
+18.63% | 21.66B | |
+3.79% | 20.94B | |
+53.22% | 18.34B | |
+2.95% | 16.73B |
- Stock Market
- Equities
- ACE Stock
- Financials Acusensus Limited